Oncology Institute Inc (NASDAQ: TOI) kicked off on Monday, down -6.31% from the previous trading day, before settling in for the closing price of $2.78. Over the past 52 weeks, TOI has traded in a range of $0.13-$3.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 46.48%. With a float of $38.73 million, this company’s outstanding shares have now reached $88.93 million.
In an organization with 825 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 10.42%, operating margin of -12.91%, and the pretax margin is -15.96%.
Oncology Institute Inc (TOI) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of Oncology Institute Inc is 56.57%, while institutional ownership is 15.18%. The most recent insider transaction that took place on Jun 05 ’25, was worth 2,054,712. In this transaction Director of this company sold 673,676 shares at a rate of $3.05, taking the stock ownership to the 13,950,557 shares. Before that another transaction happened on Jun 05 ’25, when Company’s Director sold 76,324 for $3.05, making the entire transaction worth $232,788. This insider now owns 1,272,724 shares in total.
Oncology Institute Inc (TOI) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.48% per share during the next fiscal year.
Oncology Institute Inc (NASDAQ: TOI) Trading Performance Indicators
Take a look at Oncology Institute Inc’s (TOI) current performance indicators. Last quarter, stock had a quick ratio of 1.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.09 in one year’s time.
Technical Analysis of Oncology Institute Inc (TOI)
Let’s dig in a bit further. During the last 5-days, its volume was 2.76 million. That was better than the volume of 1.19 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 8.78%. Additionally, its Average True Range was 0.35.
During the past 100 days, Oncology Institute Inc’s (TOI) raw stochastic average was set at 71.34%, which indicates a significant increase from 16.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 91.77% in the past 14 days, which was lower than the 139.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.48, while its 200-day Moving Average is $0.97. However, in the short run, Oncology Institute Inc’s stock first resistance to watch stands at $2.76. Second resistance stands at $2.92. The third major resistance level sits at $3.05. If the price goes on to break the first support level at $2.47, it is likely to go to the next support level at $2.33. The third support level lies at $2.17 if the price breaches the second support level.
Oncology Institute Inc (NASDAQ: TOI) Key Stats
The company with the Market Capitalisation of 231.90 million has total of 89,234K Shares Outstanding. Its annual sales at the moment are 393,410 K in contrast with the sum of -64,660 K annual income. Company’s last quarter sales were recorded 104,410 K and last quarter income was -19,590 K.
